Emerging Roles of Using Small Extracellular Vesicles as an Anti-Cancer Drug

Area of Science:

• Biomedical Engineering
• Oncology
• Nanotechnology

Background:

• Small extracellular vesicles (sEVs) are increasingly recognized for their therapeutic potential in oncology.
• Tumor-derived sEVs possess biomolecules valuable for cancer diagnosis and treatment.
• sEVs can directly induce tumor cell death or modify the tumor microenvironment for anti-cancer effects.

Purpose of the Study:

• To review the multifaceted applications of sEVs in cancer therapy and diagnosis.
• To compare the therapeutic efficacy of sEVs with current immune checkpoint inhibitors.
• To discuss strategies for sEV engineering and scalable manufacturing for clinical translation.

Main Methods:

• Literature review of current research on sEVs in cancer.
• Comparative analysis of sEV efficacy against immune checkpoint inhibitors.
• Exploration of sEV engineering techniques and GMP-compliant production methods.

Main Results:

• sEVs demonstrate potential as diagnostic biomarkers and drug delivery vehicles.
• Engineered sEVs can enhance therapeutic outcomes in preclinical cancer models.
• Scalable manufacturing of sEVs is crucial for clinical application.

Conclusions:

• sEVs represent a promising platform for novel cancer diagnostics and therapeutics.
• Further research into sEV engineering and manufacturing is essential for clinical translation.
• sEV-based strategies offer a potential advancement over existing cancer treatments.